Skip to main content
. 2022 Jun 25;13(6):568. doi: 10.1038/s41419-022-05004-3

Fig. 1. S100A11 expression is upregulated and predicts poor prognosis of patients with PDAC.

Fig. 1

A Analysis of S100A11 protein expression in PDAC and paracancerous tissues through IHC-based TMA (inset: 20× magnified image). B, D Violin plots demonstrating the difference in S100A11 expression between PDAC and paired paracancerous samples in the TMA cohort and TCGA database, respectively. C, E Kaplan–Meier analyses of the association between S100A11 expression and OS of PDAC from the TMA cohort and TCGA database, respectively. F Correlation analysis between the S100A11 expression and clinicopathological characteristics using online TCGA case cohort. G, H Univariate and multivariate Cox regression analyses of the relationship between the expression of S100A11 and clinicopathological factors with TCGA database. T, pancreatic cancer tissues. NT, normal paracancerous tissues. *p < 0.05.